KRAS and lung carcinoma: Mice bearing primary KRAS-mutant lung cancer xenografts (LACPDX) were treated with vehicle, etoposide (10 mg/kg body weight), FX1 (5 mg/kg body weight) or both drugs in combination for 24 days.